Michael Benkowitz, PRESIDENT AND COO at UNITED THERAPEUTICS Corp (UTHR), sold 45,000 shares at $481.63 ($21.6M) on 2025-12-01, disclosed to the SEC on 2025-12-02.
Scheduled sale ($21.6M) by PRESIDENT AND COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $477.94 | 1,065 | $509K | 2.4% |
| 2 | $477.94 | 1,978 | $945K | 4.4% |
| 3 | $477.94 | 1,978 | $945K | 4.4% |
| 4 | $477.94 | 1,065 | $509K | 2.4% |
| 5 | $478.98 | 1,581 | $757K | 3.5% |
| 6 | $478.98 | 2,935 |
| $1.4M |
| 6.5% |
| 7 | $478.98 | 2,935 | $1.4M | 6.5% |
| 8 | $478.98 | 1,581 | $757K | 3.5% |
| 9 | $479.79 | 4,545 | $2.2M | 10.1% |
| 10 | $479.79 | 2,447 | $1.2M | 5.4% |
| 11 | $479.79 | 2,447 | $1.2M | 5.4% |
| 12 | $479.79 | 4,545 | $2.2M | 10.1% |
| 13 | $480.80 | 2,904 | $1.4M | 6.5% |
| 14 | $480.80 | 2,904 | $1.4M | 6.5% |
| 15 | $480.80 | 1,563 | $751K | 3.5% |
| 16 | $480.80 | 1,563 | $751K | 3.5% |
| 17 | $481.63 | 1,691 | $814K | 3.8% |
| 18 | $481.63 | 911 | $439K | 2.0% |
| 19 | $481.63 | 1,691 | $814K | 3.8% |
| 20 | $481.63 | 911 | $439K | 2.0% |
| 21 | $482.69 | 338 | $163K | 0.8% |
| 22 | $482.69 | 338 | $163K | 0.8% |
| 23 | $482.69 | 182 | $88K | 0.4% |
| 24 | $482.69 | 182 | $88K | 0.4% |
| 25 | $483.42 | 234 | $113K | 0.5% |
| 26 | $483.42 | 126 | $61K | 0.3% |
| 27 | $483.42 | 234 | $113K | 0.5% |
| 28 | $483.42 | 126 | $61K | 0.3% |
| Total | $479.92 avg | 45,000 | $21.6M | 100% |
| Filing → |
| UTHR | SELL | 2026-02-10 | $21.4M | — | Filing → |
| UTHR | SELL | 2026-02-03 | $21.2M | — | Filing → |
| UTHR | SELL | 2026-01-28 | $13.5M | — | Filing → |